Literature DB >> 32419873

Extra-Nodal Marginal Zone Lymphoma (MZL) of MALT CD20+ of the Ocular Adnexa: Case Report.

Wulyo Rajabto1, Andi Putra Kevinsyah1.   

Abstract

Even though rare in the orbital region, lymphomas are reported as the third most common malignancies of the conjunctiva, following squamous cell carcinoma and melanoma. It is estimated that more than 95% lymphomas in periocular tissues are B cell in origin. We present a case of extra-nodal marginal zone lymphoma (MZL) of MALT type of the ocular adnexa, successfully treated with chemoimmunotherapy R-CVP.

Entities:  

Year:  2020        PMID： 32419873      PMCID： PMC7221267          DOI： 10.26574/maedica.2020.15.1.126

Source DB:  PubMed          Journal:  Maedica (Bucur)        ISSN： 1841-9038


  7 in total

1.  Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.

Authors:  Frédéric Charlotte; Kamal Doghmi; Nathalie Cassoux; Hongtao Ye; Ming-Qing Du; Michèle Kujas; Annette Lesot; George Mansour; Phuc Lehoang; Nicole Vignot; Frédérique Capron; Véronique Leblond
Journal:  Virchows Arch       Date:  2005-12-02       Impact factor: 4.064

2.  Rituximab for the treatment of extranodal marginal zone B-cell lymphoma of the lacrimal gland.

Authors:  Carsten Heinz; Hartmut Merz; Matthias Nieschalk; Heribert Mueller-Miny; Peter Koch; Arnd Heiligenhaus
Journal:  Br J Ophthalmol       Date:  2007-11       Impact factor: 4.638

Review 3.  Malignant lymphoma of the conjunctiva.

Authors:  Marina M Kirkegaard; Sarah E Coupland; Jan U Prause; Steffen Heegaard
Journal:  Surv Ophthalmol       Date:  2015-05-21       Impact factor: 6.048

4.  Conjunctival Tumors: Review of Clinical Features, Risks, Biomarkers, and Outcomes--The 2017 J. Donald M. Gass Lecture.

Authors:  Carol L Shields; Jason L Chien; Thamolwan Surakiatchanukul; Kareem Sioufi; Sara E Lally; Jerry A Shields
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2017 Mar-Apr

5.  Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type.

Authors:  Annarita Conconi; Giovanni Martinelli; Catherine Thiéblemont; Andrés J M Ferreri; Liliana Devizzi; Fedro Peccatori; Maurilio Ponzoni; Ennio Pedrinis; Stefania Dell'Oro; Giancarlo Pruneri; Virginio Filipazzi; Pierre-Yves Dietrich; Alessandro M Gianni; Bertrand Coiffier; Franco Cavalli; Emanuele Zucca
Journal:  Blood       Date:  2003-07-03       Impact factor: 22.113

Review 6.  Extranodal marginal zone lymphoma of the ocular adnexa.

Authors:  Alexandra Stefanovic; Izidore S Lossos
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

7.  Long-term outcome of 487 patients with early-stage extra-nodal marginal zone lymphoma.

Authors:  S Teckie; S Qi; M Chelius; S Lovie; M Hsu; A Noy; C Portlock; J Yahalom
Journal:  Ann Oncol       Date:  2017-05-01       Impact factor: 32.976
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.